CN105055667A - 一种含滇山茶叶提取物的复合美白组合物、制剂及其制备方法 - Google Patents
一种含滇山茶叶提取物的复合美白组合物、制剂及其制备方法 Download PDFInfo
- Publication number
- CN105055667A CN105055667A CN201510559435.4A CN201510559435A CN105055667A CN 105055667 A CN105055667 A CN 105055667A CN 201510559435 A CN201510559435 A CN 201510559435A CN 105055667 A CN105055667 A CN 105055667A
- Authority
- CN
- China
- Prior art keywords
- preparation
- flos camelliae
- camelliae japonicae
- leaf extract
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 103
- 230000002087 whitening effect Effects 0.000 title claims abstract description 91
- 239000000203 mixture Substances 0.000 title claims abstract description 76
- 239000002131 composite material Substances 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 44
- 240000001238 Gaultheria procumbens Species 0.000 title abstract 4
- 235000007297 Gaultheria procumbens Nutrition 0.000 title abstract 4
- 235000010394 Solidago odora Nutrition 0.000 title abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000008367 deionised water Substances 0.000 claims abstract description 21
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 21
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 14
- 229960000458 allantoin Drugs 0.000 claims abstract description 14
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 14
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 claims abstract description 14
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000004166 Lanolin Substances 0.000 claims abstract description 13
- 235000004433 Simmondsia californica Nutrition 0.000 claims abstract description 13
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims abstract description 13
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 13
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940081733 cetearyl alcohol Drugs 0.000 claims abstract description 13
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 13
- 229960005150 glycerol Drugs 0.000 claims abstract description 13
- 229940039717 lanolin Drugs 0.000 claims abstract description 13
- 235000019388 lanolin Nutrition 0.000 claims abstract description 13
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 13
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 13
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 13
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 13
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 13
- 229950011392 sorbitan stearate Drugs 0.000 claims abstract description 13
- 239000008117 stearic acid Substances 0.000 claims abstract description 13
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 12
- 229920001214 Polysorbate 60 Polymers 0.000 claims abstract description 10
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims abstract description 9
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims abstract description 9
- 229940113124 polysorbate 60 Drugs 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 47
- 239000000463 material Substances 0.000 claims description 36
- 230000001804 emulsifying effect Effects 0.000 claims description 22
- 239000008346 aqueous phase Substances 0.000 claims description 21
- 239000012071 phase Substances 0.000 claims description 20
- 241001295692 Pyracantha fortuneana Species 0.000 claims description 19
- 241000933832 Broussonetia Species 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 241000221095 Simmondsia Species 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 9
- 239000000498 cooling water Substances 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 7
- 239000006185 dispersion Substances 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 238000004440 column chromatography Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- 241000705930 Broussonetia papyrifera Species 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 11
- 239000002537 cosmetic Substances 0.000 abstract description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 abstract 1
- 244000044822 Simmondsia californica Species 0.000 abstract 1
- 229920002385 Sodium hyaluronate Polymers 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 229940093629 isopropyl isostearate Drugs 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229940010747 sodium hyaluronate Drugs 0.000 abstract 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 239000013641 positive control Substances 0.000 description 12
- 229960000271 arbutin Drugs 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000002752 melanocyte Anatomy 0.000 description 6
- 210000003574 melanophore Anatomy 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 208000003351 Melanosis Diseases 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 206010008570 Chloasma Diseases 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XGKPLOKHSA-N [2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XGKPLOKHSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 238000012422 test repetition Methods 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 例数 | 基本治愈 | 显效 | 好转 | 无效 | 总有效率 |
试验组 | 30 | 0 | 5 | 9 | 16 | 46.6% |
对照组 | 30 | 0 | 2 | 5 | 23 | 23.3% |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510559435.4A CN105055667B (zh) | 2015-09-06 | 2015-09-06 | 一种含滇山茶叶提取物的复合美白组合物、制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510559435.4A CN105055667B (zh) | 2015-09-06 | 2015-09-06 | 一种含滇山茶叶提取物的复合美白组合物、制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105055667A true CN105055667A (zh) | 2015-11-18 |
CN105055667B CN105055667B (zh) | 2017-12-05 |
Family
ID=54485345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510559435.4A Active CN105055667B (zh) | 2015-09-06 | 2015-09-06 | 一种含滇山茶叶提取物的复合美白组合物、制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105055667B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107260612A (zh) * | 2017-07-06 | 2017-10-20 | 昆明贝泰妮生物科技有限公司 | 祛除黄褐斑组合物、应用、复合制剂及制备方法 |
CN108261358A (zh) * | 2016-12-31 | 2018-07-10 | 伽蓝(集团)股份有限公司 | 一种白山茶复合提取物及其应用 |
CN108653478A (zh) * | 2017-09-06 | 2018-10-16 | 四川云想科技有限公司 | 一种抗菌消炎外用涂剂及其制备方法和用途 |
CN110559243A (zh) * | 2019-09-26 | 2019-12-13 | 上海清轩生物科技有限公司 | 含山茶提取物的修复美白组合物及其制备的微胶囊 |
CN113413336A (zh) * | 2021-07-05 | 2021-09-21 | 云南西草资源开发有限公司 | 一种添加松茸发酵提取物的美白组合物及制备方法和应用 |
CN114788796A (zh) * | 2022-03-10 | 2022-07-26 | 河南省纳普生物技术有限公司 | 一种含福鼎白茶提取物的美白抗菌化妆品及其制备方法 |
WO2022227286A1 (zh) * | 2021-04-27 | 2022-11-03 | 云南英格生物技术有限公司 | 火棘果提取物的制备方法和用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102970999A (zh) * | 2010-07-02 | 2013-03-13 | 株式会社爱茉莉太平洋 | 含有构树的花朵和果实的提取液的皮肤外用的皮肤美白组合物 |
CN103083210A (zh) * | 2013-01-25 | 2013-05-08 | 王恩瀚 | 具有美白皮肤作用的药物组合物及其制备方法和应用 |
-
2015
- 2015-09-06 CN CN201510559435.4A patent/CN105055667B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102970999A (zh) * | 2010-07-02 | 2013-03-13 | 株式会社爱茉莉太平洋 | 含有构树的花朵和果实的提取液的皮肤外用的皮肤美白组合物 |
CN103083210A (zh) * | 2013-01-25 | 2013-05-08 | 王恩瀚 | 具有美白皮肤作用的药物组合物及其制备方法和应用 |
Non-Patent Citations (3)
Title |
---|
雷杨等: "构树提取物的美白活性研究", 《香料香精化妆品》 * |
黄晓凤: "滇山茶等植物提取物对人表皮黑素细胞株增殖活性和酪氨酸酶影响的研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
黄荣等: "火棘黄酮的提取及美白功效研究", 《化学应用与研究》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108261358A (zh) * | 2016-12-31 | 2018-07-10 | 伽蓝(集团)股份有限公司 | 一种白山茶复合提取物及其应用 |
CN107260612A (zh) * | 2017-07-06 | 2017-10-20 | 昆明贝泰妮生物科技有限公司 | 祛除黄褐斑组合物、应用、复合制剂及制备方法 |
CN107260612B (zh) * | 2017-07-06 | 2020-08-11 | 云南贝泰妮生物科技集团股份有限公司 | 祛除黄褐斑组合物、应用、复合制剂及制备方法 |
CN108653478A (zh) * | 2017-09-06 | 2018-10-16 | 四川云想科技有限公司 | 一种抗菌消炎外用涂剂及其制备方法和用途 |
CN110559243A (zh) * | 2019-09-26 | 2019-12-13 | 上海清轩生物科技有限公司 | 含山茶提取物的修复美白组合物及其制备的微胶囊 |
WO2022227286A1 (zh) * | 2021-04-27 | 2022-11-03 | 云南英格生物技术有限公司 | 火棘果提取物的制备方法和用途 |
CN113413336A (zh) * | 2021-07-05 | 2021-09-21 | 云南西草资源开发有限公司 | 一种添加松茸发酵提取物的美白组合物及制备方法和应用 |
CN114788796A (zh) * | 2022-03-10 | 2022-07-26 | 河南省纳普生物技术有限公司 | 一种含福鼎白茶提取物的美白抗菌化妆品及其制备方法 |
CN114788796B (zh) * | 2022-03-10 | 2023-08-25 | 河南省纳普生物技术有限公司 | 一种含福鼎白茶提取物的美白抗菌化妆品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105055667B (zh) | 2017-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105055667A (zh) | 一种含滇山茶叶提取物的复合美白组合物、制剂及其制备方法 | |
CN105769698B (zh) | 一种不含防腐剂的化妆品组合物及其应用 | |
CN105616283B (zh) | 一种植物精粹修护面霜 | |
CA2444282C (en) | Preparation for hair and/or scalp | |
CN105534796B (zh) | 一种含有艾叶提取物的抗过敏爽肤水及其制备方法 | |
AU2007361455A1 (en) | Topical cosmetic skin lightening compositions and methods of use thereof | |
KR20100132511A (ko) | 주름을 방지 또는 개선하기 위한 경구, 주사, 피부 외용제 및 미용 방법 | |
JP7421463B2 (ja) | 頭皮用剤 | |
CN103442691A (zh) | 包含拟爱神木和腰果树果肉及其提取物的局部护肤制剂 | |
CN110279635A (zh) | 通过表皮微生态调节有效祛痘的配方工艺 | |
CN105555366A (zh) | 海马齿苋提取物及其应用 | |
CN109078119A (zh) | 一种保湿抗衰老中药组合物及其应用 | |
US20190269738A1 (en) | Camelid compound(s), composition(s) and method(s) | |
KR20130069512A (ko) | 텐저레틴을 함유하는 피부 외용제 조성물 | |
Sandeep et al. | Green tea polyphenols: versatile cosmetic ingredient | |
CN104435366A (zh) | 一种含药草提取物的组合物,化妆料组合物 | |
CN102232917A (zh) | 一种中药组合提取物在美白保湿产品中的应用 | |
KR101817514B1 (ko) | 헤스페레틴의 신규 용도 | |
CN1794967B (zh) | 含有白藜芦醇的美白抗氧化化妆合成物及其制备方法 | |
KR101509848B1 (ko) | 탄시논ⅱa를 유효성분으로 함유하는 피부 외용제 조성물 | |
CN103446026B (zh) | 一种当归保湿水及其制备方法 | |
JP2020193227A (ja) | 外用組成物 | |
CN109453088B (zh) | 美白紧致霜及其制备方法和酪氨酸酶抑制剂 | |
JP2010100554A (ja) | メラニン生成抑制剤 | |
CN105663595B (zh) | 一种黑色素抑制剂、护肤组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180606 Address after: 650000 Kunming hi tech Zone, Yunnan Province, Department of medicine No. 53 Patentee after: KUNMING BOTANEE BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 650000 the First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming, Yunnan Patentee before: He Li |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 650106 No. 53, medical Road, hi tech Zone, Yunnan, Kunming Patentee after: Yunnan Beitani Biotechnology Group Co., Ltd. Address before: 650000 No. 53 Keyi Road, Kunming High-tech Zone, Yunnan Province Patentee before: KUNMING BOTANEE BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address |